Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Atsutaka Yasui"'
Autor:
Dae Jung Kim, Wayne H‐H Sheu, Wook‐Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia‐Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz‐Luyet, Moe H Kyaw, Yutaka Seino, EMPRISE East Asia Study Group
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 3, Pp 417-428 (2023)
Abstract Aims/Introduction The EMPA‐REG OUTCOME® trial demonstrated benefits of empagliflozin, a sodium‐glucose cotransporter‐2 inhibitor (SGLT2i), on cardiovascular, renal outcomes and all‐cause mortality in patients with type 2 diabetes an
Externí odkaz:
https://doaj.org/article/4fadce44738c43919f7eaceb3654a8a9
Autor:
Wayne H‐H Sheu, Yutaka Seino, Elise Chia‐Hui Tan, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Wook‐Jin Chung, Koichi Node, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Anastasia Ustyugova, Riho Klement, Anouk Deruaz‐Luyet, Moe H Kyaw, Dae Jung Kim, the EMPRISE East Asia study group
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 5, Pp 810-821 (2022)
ABSTRACT Aims/Introduction We investigated the utilization of healthcare resources in patients with type 2 diabetes treated with empagliflozin, a sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor, versus dipeptidyl peptidase‐4 (DPP‐4) inhib
Externí odkaz:
https://doaj.org/article/7f7c784bc36e45fdb973717cf420b9e6
Autor:
Daisuke Yabe, Atsutaka Yasui, Linong Ji, Moon‐Kyu Lee, Ronald Ching Wan Ma, Tien‐Jyun Chang, Tomoo Okamura, Cordula Zeller, Stefan Kaspers, Jisoo Lee, Sven Kohler, Yutaka Seino
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 2, Pp 418-428 (2019)
Abstract Aims/Introduction We investigated the safety and tolerability of empagliflozin (EMPA) in East Asian patients with type 2 diabetes. Materials and Methods Data were pooled from participants with type 2 diabetes evenly randomized to a placebo,
Externí odkaz:
https://doaj.org/article/b35669965275441882e14bb65c54f37b
Autor:
Daisuke Yabe, Yutaka Seino, Kosuke Shiki, Keiko Suzaki, Thomas Meinicke, Yutaro Kotobuki, Kenichiro Nishida, Douglas Clark, Atsutaka Yasui
Publikováno v:
BMJ Open, Vol 11, Iss 4 (2021)
Introduction Elderly people (≥65 years) with type 2 diabetes mellitus (T2DM) are becoming increasingly prevalent, notably in Japan. As cardiovascular (CV) risk increases with age and sodium–glucose cotransporter-2 (SGLT2) inhibitors reduce CV ris
Externí odkaz:
https://doaj.org/article/9a9d76069e914df987b41e790c1c715c
Autor:
Yutaka Seino, Dae Jung Kim, Daisuke Yabe, Elise Chia‐Hui Tan, Wook‐Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Moe H. Kyaw, Anouk Deruaz‐Luyet, Kimberly G. Brodovicz, Wayne H.‐H. Sheu, the EMPRISE East Asia study group
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 1, Pp n/a-n/a (2021)
Abstract Aim To evaluate the effectiveness of empagliflozin in clinical practice in East Asia in the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) East Asia study. Materials and methods Data were obtained from the Medical Data Vision d
Externí odkaz:
https://doaj.org/article/b9d082c7bc384035bc5f92b568082777
Publikováno v:
Journal of Diabetes Investigation. 14:417-428
Autor:
Kohei Kaku, Christoph Wanner, Stefan D. Anker, Stuart Pocock, Atsutaka Yasui, Michaela Mattheus, Søren S. Lund
Publikováno v:
Diabetes, Obesity and Metabolism. 24:662-674
Autor:
Atsutaka Yasui1 atsutaka.yasui@boehringer-ingelheim.com, Ganghyuck Lee1, Tetsuaki Hirase2, Tatsuroh Kaneko1, Kaspers, Stefan3, von Eynatten, Maximilian3, Tomoo Okamura1 tomoo.okamura@boehringer-ingelheim.com
Publikováno v:
Diabetes Therapy. Apr2018, Vol. 9 Issue 2, p863-871. 9p.
Autor:
Akira Nishiyama, Atsutaka Yasui, Jens Titze, Tatsuroh Kaneko, Adriana Marton, Kento Kitada, Jean-Paul Kovalik
Publikováno v:
Nature Reviews Nephrology. 17:65-77
Therapeutic inhibition of the sodium–glucose co-transporter 2 (SGLT2) leads to substantial loss of energy (in the form of glucose) and additional solutes (in the form of Na+ and its accompanying anions) in urine. However, despite the continuously e
Publikováno v:
Clinical Epidemiology. 12:367-375
Background Observational studies using large claims databases for diabetes patients have been increasingly conducted. While validation of outcomes is important in such studies, validation studies from Japan are still scarce and small in scale with qu